-
Screening Gets Personal
Conflicting and changing cancer screening guidelines have led to uncertainty and controversy. Can screening recommendations tailored for groups or individuals enhance benefits and reduce harms?
by Kate Yandell
-
Making a Match
Oncologists and researchers are looking for new drug combinations that extend patient survival without worsening side effects, but it's a daunting task.
by Stephen Ornes
-
Healthy Habits
Reaping Grains’ BenefitsStudies point to a reduced risk of cancer death from eating whole grains, but questions remain.
by Brenda Conaway
-
Healthy Habits
Put a Cork in ItDrinking alcohol increases the risk for at least seven types of cancer.
by Brenda Conaway
-
Healthy Habits
Fruitful ChoicesEating fruits in teen years associated with lower breast cancer risk later.
by Lindsey Konkel
-
Healthy Habits
Prioritize PreventionHealthier lifestyles could cut cancer deaths in half.
by Kendall K. Morgan
-
From the Editor-in-Chief
Geriatric Oncology: Cancer Care Comes of Age?A medical subspecialty focusing on older adults with cancer is emerging as the U.S. population ages.
by William G. Nelson, MD, PhD
-
Forward Look
All About OverdiagnosisQ&A with epidemiologist Pam Marcus on why cancer screening can have risks.
by Sue Rochman
-
Forward Look
Thyroid Tumor Gets New NamePanel reclassifies a type of thyroid tumor, says it's not cancer.
by Yasmine Iqbal
Cancer Talk
Lessons Learned as a Caregiver and Patient
After caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons